Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview
MedComm · 2026-06 · 7 (6)
DOI: 10.1002/mco2.70799 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 07.06.2026. Verfasst von Mukta Lele und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Technology, Marathwada Campus Jalna Maharashtra India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Deuterium, the heavy isotope of hydrogen, has unfolded as a cornerstone in modern drug discovery due to its potential to influence metabolic stability and pharmacokinetic behavior. The deuterium kinetic isotope effect (KIE), which strengthens carbon–deuterium bonds, make it possible to improve therapeutic efficacy while maintaining pharmacological activity. Although some deuterated drugs, notably donafenib and deutetrabenazine, have demonstrated clinically significant efficacy, their limited use is an effect of ongoing challenges with metabolic switching and species‐specific variation, as well as inadequate mechanistic understanding. This review presents a systematic discussion of the recent innovations in site‐selective deuteration, the principles that underpin the KIE process, and the effects of deuterium substitution on drug metabolism, toxicity, and blood–brain barrier penetration. It illustrates novel implications in oncology, rare diseases, and central nervous system disorders, as well as the integration of deuterated chemistry with modalities such as proteolysis‐targeting chimaeras, peptides, and nucleic acid therapeutics. Furthermore, the review's discussion includes the current challenges, synthesis, analytical limits, and regulatory considerations that influence further development. Overall, the review offers a strategic roadmap for utilizing deuterium‐enabled molecular engineering to accelerate the development of next‐generation precision medicine, guiding rational design, innovation toward safer, longer‐lasting, and more effective treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemical Technology, Marathwada Campus Jalna Maharashtra India.
- Department of Pharmaceutics St. John Institute of Pharmacy and Research Palghar Maharashtra India.
- Institute For Bioengineering of Catalonia (IBEC) Barcelona Spain.
- NICM Health Research Institute & School of Science Western Sydney University Westmead NSW Australia.
- Woolcock Institute of Medical Research Macquarie University Sydney New South Wales Australia.
- Institute for Translational Medicine and Pharmacology, Department of Pharmacological Sciences Icahn School of Medicine at Mount Sinai New York New York USA.
ORCID-Profile: Krishna Jadhav, Keshav Raj Paudel
Zitieren
APA
Lele, M., Manchare, A., Parit, S., Gholap, A. D., Jadhav, K., Hatvate, N., Paudel, K. R., & Rojekar, S. (2026). Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview. MedComm, 7(6). https://doi.org/10.1002/mco2.70799
Vancouver
Lele M, Manchare A, Parit S, Gholap AD, Jadhav K, Hatvate N, et al. Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview. MedComm. 2026;7(6). doi:10.1002/mco2.70799
BibTeX
@article{Lele2026,
author = {Lele, Mukta and Manchare, Ajit and Parit, Swapnali and Gholap, Amol D and Jadhav, Krishna and Hatvate, Navnath and Paudel, Keshav Raj and Rojekar, Satish},
title = {Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview},
journal = {MedComm},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/mco2.70799}
}
EUVIMED